Lung Disease Clinical Trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Athens Alabama 35611

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35294

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35216

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35215

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Inhaled Treprostinil and Placebo for patients with Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

View More ▼

UPDATED

Birmingham Alabama

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

UPDATED

Florence Alabama 35630

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Jasper Alabama 35501

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Mobile Alabama 36608

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Muscle Shoals Alabama 35662

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Sheffield Alabama 35660

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

*see Various Departments* Alabama

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama 36420

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Andalusia Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Anniston Alabama 36207-5710

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama 35233

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Gulf Shores Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Jasper Alabama

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Montgomery Alabama

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Arizona

UPDATED

Chandler Arizona 85284

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Flagstaff Arizona 86001

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Glendale Arizona 85306

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Peoria Arizona 85381

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Phoenix Arizona 85018

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

View More ▼

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Tucson Arizona 85724-5023

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Tucson Arizona 85723

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating KD025 and Standard of Care for the treatment of Idiopathic Pulmonary Fibrosis

Additional Locations Arizona

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Flagstaff Arizona 86001

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Glendale Arizona

A clinical trial seeking patients for a research study for the treatment of Lung Cancer or Non Small Cell Lung Cancer.

Peoria Arizona 85381

Patients are needed to participate in a clinical research study of Lebrikizumab and Placebo to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona 85006

A clinical research study of Batefenterol + Fluticasone Furoate, Placebo and Albuterol for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of Fluzone to evaluate Chronic Obstructive Pulmonary Disease

Redmond Arizona 97756

A clinical trial seeking patients for a research study for the treatment of Lung Cancer or Non Small Cell Lung Cancer.

Tempe Arizona 85283

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona 85723

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona 85712

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tucson Arizona

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Arkansas

Fayetteville Arkansas 72703

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fort Smith Arkansas 72901

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

California

UPDATED

Arcadia California 91007

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

UPDATED

Bakersfield California 93301

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive